Exclusion Criteria:~* Subject has experienced a serious adverse event during the parent study, which could
present an increased safety risk during the open label extension.~* New diagnosis of severe major depressive
disorder even without psychotic features.~* Any subject with formalized delusions or hallucinations.~*
Significant suicide risk.~* Newly-diagnosed malignant tumor, except for the following conditions that are
stable in the judgement of the investigator:~ * Adequately treated squamous and basal cell carcinoma, or
squamous and basal cell carcinoma in situ~ * Prostate carcinoma in situ
